Mednet Logo
HomePrimary Care
Primary Care

Primary Care

Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.

Recent Discussions

What do you think about using conventional thoracic imaging methods (e.g., X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?

2
4 Answers

Mednet Member
Mednet Member
Hospital Medicine · Baylor University Medical Center

Generally speaking, CT would be superior as it would allow you to see more volumetric characteristics of the effusion; XR would have a hard time discerning true size, presence of loculations, or trapped lung. The real winner for this application would be bedside ultrasound. This modality would give ...

What do you think about using conventional thoracic imaging methods (e.g., X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?

2
4 Answers

Mednet Member
Mednet Member
Hospital Medicine · Baylor University Medical Center

Generally speaking, CT would be superior as it would allow you to see more volumetric characteristics of the effusion; XR would have a hard time discerning true size, presence of loculations, or trapped lung. The real winner for this application would be bedside ultrasound. This modality would give ...

How often do you recommend performing an advanced lipid panel for monitoring of lipid lowering therapy?

1
4 Answers

Mednet Member
Mednet Member
Endocrinology · University of Washington

I am late to the responses, but I do not ever order an advanced lipid panel. Our institution does not have it on the lab menu either (one has to go to an outside lab to get it done). Anything needed for CV risk assessment can be gleaned from the history, including family history and a standard lipid...

How often do you recommend performing an advanced lipid panel for monitoring of lipid lowering therapy?

1
4 Answers

Mednet Member
Mednet Member
Endocrinology · University of Washington

I am late to the responses, but I do not ever order an advanced lipid panel. Our institution does not have it on the lab menu either (one has to go to an outside lab to get it done). Anything needed for CV risk assessment can be gleaned from the history, including family history and a standard lipid...

How do you balance the risks versus benefits of starting a statin in a patient with MASLD and a persistent but mild elevation in their AST/ALT?

1 Answers

Mednet Member
Mednet Member
Primary Care · Mount Sinai Doctors Medical Group

I no longer hesitate to start a statin despite mild ast/alt elevation. I might just check lfts again in a few months, but if there is a clear indication for the statin we go ahead and do it.

How do stroke-risk considerations affect your use of atypical antipsychotics for patients with dementia?

1
2 Answers

Mednet Member
Mednet Member
Psychiatry · Thapar Renu K Office

Antipsychotics carry a number of risks, including a warning of sudden death in elderly demented patients. If nothing else works for a behavioral problem, you have to use an antipsychotic. Also, for frank paranoia, which is not only causing distress to parents but also to the environment, treatment w...

Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?

3
1 Answers

Mednet Member
Mednet Member
Primary Care · Montefiore Wakefield Ambulatory Care Center

Women lose one T-score unit (10-12%) of bone mass on average during menopause. Estrogen, as a part of menopausal hormone therapy (MHT), is approved by the FDA to prevent osteoporosis, but not for its treatment. Upon MHT discontinuation, women will experience a period of rapid bone loss, for which st...

Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?

3
1 Answers

Mednet Member
Mednet Member
Primary Care · Montefiore Wakefield Ambulatory Care Center

Women lose one T-score unit (10-12%) of bone mass on average during menopause. Estrogen, as a part of menopausal hormone therapy (MHT), is approved by the FDA to prevent osteoporosis, but not for its treatment. Upon MHT discontinuation, women will experience a period of rapid bone loss, for which st...

How do you differentiate cognitive impairment from normal age-related cognitive decline?

2
2 Answers

Mednet Member
Mednet Member
Geriatric Medicine · University Of California (San Francisco)

Dr. @Dr. First Last's answer is right on target. I have a couple of additional tips when taking a history. First: normal cognitive decline would include certain features and not others. Normal aging typically leads to slower processing, more effort with multitasking and learning something new, and m...

How do you approach the management of aortic stenosis in an elderly, frail patient with multiple comorbidities who is symptomatic but considered high risk for surgical aortic valve replacement?

1
3 Answers

Mednet Member
Mednet Member
Cardiology · Washington University School of Medicine

In an older patient with severe aortic stenosis (AS) who is not a candidate for surgery, there are 3 treatment options – TAVR, balloon aortic valvuloplasty (BAV), and medical management.In the original PARTNER trial, 358 patients with severe AS who, in the judgement of at least 2 cardiac surgeons, w...